Off-Label Use of Ketamine for the Treatment of Patients With Mood Disorders
Ketamine dosing continues to raise safety concerns.
Ketamine dosing continues to raise safety concerns.
Neuroimaging studies have shown several neurophysiological substrates for depression: An overview by Theodore Henderson, MD, PhD.
Byproduct of ketamine metabolism underlies the antidepressant-like activity of the agent in mice.
China’s U.N. delegation has argued that ketamine is a health risk when it is used in a recreational fashion.
Ketamine and other drugs targeting the brain’s NMDA receptors may benefit treatment-resistant depression.